BlackRock Institutional Trust’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

BlackRock Institutional Trust’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-65,386	Closed	-$30K	–	4010
2016 Q2	$30K	Sell	65,386 -42,871	-40%	-$68.8K	﹤0.01%	3793
2016 Q1	$291K	Sell	108,257 -19,584	-15%	-$55K	﹤0.01%	3555
2015 Q4	$395K	Buy	127,841 +70,491	+123%	+$318K	﹤0.01%	3546
2015 Q3	$253K	Sell	57,350 -51,795	-47%	-$304K	﹤0.01%	3610
2015 Q2	$623K	Buy	109,145 +5,918	+6%	+$40.4K	﹤0.01%	3463
2015 Q1	$924K	Buy	+103,227	New	+$829K	﹤0.01%	3365

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BlackRock Institutional Trust's EPRS Position: Q3 2016 in Review

BlackRock Institutional Trust sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 65,386 shares — an estimated $30K sold.

BlackRock Institutional Trust first reported a position in EPRS in Q1 2015 and held it in 6 quarters. The position peaked at $924K in Q1 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

BlackRock Institutional Trust reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
BlackRock Institutional Trust sold 65,386 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $30K.
BlackRock Institutional Trust first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q1 2015 and held it in 6 quarters.
BlackRock Institutional Trust's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $924K in Q1 2015.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on BlackRock Institutional Trust's 13F filing for Q3 2016, filed 8 Nov 2016.